Influence of inflammatory bowel disease on different dimensions of quality of life.
about
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsMeta-analysis: colorectal and small bowel cancer risk in patients with Crohn's diseaseInterventions for fatigue in inflammatory bowel diseaseBiomarkers for assessing disease activity in inflammatory bowel diseaseMagnetic resonance enterography or video capsule endoscopy - what do Crohn's disease patients prefer?The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patientsImpact of pain on health-related quality of life in patients with inflammatory bowel diseasePartners of patients with inflammatory bowel disease: how important is their support?The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Working Group Guidelines on the nursing roles in caring for patients with Crohn's disease and ulcerative colitis in PolandA new look at a mainstay ulcerative colitis therapyThe impact of biologics on health-related quality of life in patients with inflammatory bowel disease.Health-related quality of life in Chinese patients with mild and moderately active ulcerative colitisPharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease.Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease.Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis.Mediation analysis of relationships between chronic inflammation and quality of life in older adults.Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease.Timing of surgery in Crohn's disease: a key issue in the management.Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine.Health-related quality of life in patients with inflammatory bowel disease: a single-center experience.An evidence-based systematic review on medical therapies for inflammatory bowel disease.Efficacy and safety of adalimumab in Crohn's disease: meta-analysis of placebo-controlled trials.N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis.The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review.Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis.Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis.Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.Impact of chronic conditions on quality of life in patients with inflammatory bowel disease.Response shift and disease activity in inflammatory bowel disease.Living with Crohn's disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study).Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort.Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life.Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients.The burden of inflammatory bowel disease on health care utilization and quality of life.Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease.
P2860
Q22242050-EC9D2714-C126-4E05-85EC-3DFC8ECC3A57Q22242636-B8FA0055-D4CD-435D-85EE-7D765B48B934Q24187375-400F3C70-BBB2-4273-906D-5CFD6766F07EQ24202614-76058A4F-0BDC-4E9A-9F75-A99FFFA15E5BQ27335933-A0F4EEA0-D184-4D92-957C-0FF7F34D25ECQ33536129-F744F554-2F7A-442F-85F9-36328C7007ADQ33960394-7CF4DFAC-AAB2-4DBF-8044-CE0AFC13795EQ34004075-D600879B-A89F-4A56-B4AC-048B94FF35F6Q34152778-1AFC87D9-1AA8-4014-B1E5-BAE533401540Q34258122-9011C6B9-A469-4B8F-BF0E-141BB3955597Q34940520-0D56BF01-051C-4287-BA97-AC7F0AC449A9Q35026298-787119E8-738A-488A-8071-94C677F9792EQ35542672-1E3AD6BD-A4C5-44C3-A1A1-032C215E709FQ35895310-1E1F60BB-6338-4C88-9B36-7EE36F16B211Q36058941-9BAEAA5A-EE04-4B3C-BD89-8260C9AF9C22Q36428382-1B17646C-57DC-452B-8C15-302D2BBF4219Q36553689-59E3E261-A14D-4CFE-A19F-70A2F3AF5FF9Q36555966-65B05139-7E1B-420B-8518-91F73301C727Q36715002-D1584814-9B1D-497F-A2DA-610378870CFDQ37225167-ED02EB17-95FE-4319-88A7-99B9637AC91EQ37276979-220ABDC4-BBB9-4D28-8E63-90402C507598Q37423752-5A7412A6-C919-47E9-9B79-899615A50E5DQ37647443-4776C94E-ADFD-4443-8171-3FD70E67A9C0Q37862584-4581458F-24AB-4244-8090-8B67319C7F53Q37880288-31606B93-6F23-4AA1-9152-1459809BA008Q38119781-95BCFD87-C4FA-4C1D-A461-22008D039BE8Q38254538-1FB85D23-4A49-449B-A1AA-D481FC4199F5Q38288749-0E04D793-48FF-46A7-BE96-297C005893EFQ38378491-3D8508C9-550D-4E3D-9097-CF2B303D2FD1Q38768891-EDCA5791-F028-45E3-9A70-7D06411655C3Q39740349-C5F87A49-2627-4F6B-B6BC-6DD1DD938F91Q40294994-3FBDE880-3816-4E5E-A41C-8D21EE2E1133Q42172780-8E17E114-0456-4274-A499-593124E432A7Q44941259-45A96818-A797-4C9D-994D-C70419EC7A26Q47343398-583D2AFF-09E0-4F2B-8F96-E69BE5A2C84EQ47381227-42115497-7932-42C2-9D48-F3CB8A50623CQ47821292-9BDCDE3E-57F7-4A7F-B282-DF6F474FF546Q48038691-0E60F43A-1E46-4D8B-A582-E4F70F11B4BDQ48444160-5E561898-61DC-468E-95AB-1D141BB8882AQ48568936-D0604E61-B949-462D-8503-33022092D596
P2860
Influence of inflammatory bowel disease on different dimensions of quality of life.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Influence of inflammatory bowel disease on different dimensions of quality of life.
@en
Influence of inflammatory bowel disease on different dimensions of quality of life.
@nl
type
label
Influence of inflammatory bowel disease on different dimensions of quality of life.
@en
Influence of inflammatory bowel disease on different dimensions of quality of life.
@nl
prefLabel
Influence of inflammatory bowel disease on different dimensions of quality of life.
@en
Influence of inflammatory bowel disease on different dimensions of quality of life.
@nl
P2093
P921
P1476
Influence of inflammatory bowel disease on different dimensions of quality of life.
@en
P2093
Casellas F
López-Vivancos J
Malagelada JR
Vilaseca J
P304
P356
10.1097/00042737-200105000-00017
P577
2001-05-01T00:00:00Z